Levofloxacin Hemihydrate molecular structure

Levofloxacin Hemihydrate

Also known as: Levaquin, Tavanic, Levoflox, Neofloxin

CAS Number: 138199-71-0

Fluoroquinolone antibiotic — L-isomer of ofloxacin

Pharmacopeia Standards

USPEP

Mechanism of Action

Third-generation fluoroquinolone; S(-)-enantiomer of ofloxacin with 8–16× greater antibacterial potency than the racemate. Inhibits both DNA gyrase and topoisomerase IV with enhanced activity against gram-positive organisms (S. pneumoniae) compared to ciprofloxacin. Bioavailability ~99% (oral = IV). Once-daily oral dosing.

Technical Specifications

Generic / INN NameLevofloxacin Hemihydrate
CAS Registry Number138199-71-0
Molecular FormulaC18H20FN3O4·0.5H2O
Molecular Weight370.38 g/mol
Typical Purity98.5–101.5% (anhydrous basis)
Storage ConditionsStore below 25°C, protected from light
Shelf Life36 months from date of manufacture
CategoryFluoroquinolones

Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.

Typical Applications

Community-acquired pneumonia including penicillin-resistant S. pneumoniae (DRSP) — first-line 5-day course per guidelines, nosocomial pneumonia, acute bacterial sinusitis, COPD exacerbations, complicated UTIs and pyelonephritis, prostatitis (chronic bacterial), skin/soft tissue infections, Legionella pneumophila (preferred fluoroquinolone), anthrax (alternative).

Manufacturers (2+)

View all →
Contact (Premium)

India

WHO-GMPUS-FDAEU-GMP
Contact (Premium)